Biotech Growth (Ordinary Share) BIOG

Objective:

Management Contract & Fees:

Under a new management, administration and company secretarial agreement with Frostrow Capital LLP, Frostrow will receive a periodic fee equal to 0.30% p.a. of the market capitalisation of the Company plus a fixed amount equal to £ 60,000 p.a.. The Investment Manager received a fee equal to 0.65% p.a. of the Company's net asset value. The Investment Management Agreement may by terminated by either giving notice of not less than 12 months'. A performance fee is calculated quarterly by comparing the cumulative performance of the investment portfolio of the Company with the cumulative performance of the benchmark index since 30-Jun-05. The performance fee amounts to 16.5% of any outperformance of the NAV over the benchmark index, the Investment manager receiving 15% and Manager 1.5% of the outperformance. At each quarterly calculation date any performance fee payable is based on the lower of: (i) the cumulative outperformance of the investment portfolio over the benchmark index as at the quarter end date; and (ii) the cumulative outperformance of the investment portfolio over the benchmark as at the corresponding quarter end date in the previous year. The Contract can be terminated on 12 months' notice.